News Conference News TVT 2017 Volume Underload? More TAVRs Done, the Better the Operator Outcomes, Yet Many Patients Go Untreated Michael O'Riordan June 16, 2017
News Conference News ACC 2017 ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More Shelley Wood March 10, 2017
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for January 2017 Caitlin E. Cox February 01, 2017
News Features Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond Shelley Wood December 30, 2016
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular News and Features for 2016 Shelley Wood December 29, 2016
News Conference News AHA 2016 Amid Rising Tide of Atherosclerotic CVD, Costs of Treatment Should Spur Policy Makers to Push Prevention Yael L. Maxwell November 29, 2016
News Conference News AHA 2016 AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR Shelley Wood November 09, 2016
News Opinion Editor's Corner TCT 2016 My Takeaways From TCT 2016: Surprises, Presuppositions, and the Gift of the Giveaway Shelley Wood November 07, 2016
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for October 2016 Caitlin E. Cox October 29, 2016
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for September 2016 Shelley Wood September 30, 2016
News Daily News TAVR as an Option for Intermediate-Risk Patients: Physicians Respond Yael L. Maxwell August 24, 2016
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for April 2016 Shelley Wood April 29, 2016
News Daily News No Cause for Concern Over GME Squeeze for Med School Graduates in Coming Years Yael L. Maxwell November 05, 2015
News Opinion Editor's Corner Editor's Corner: What to Expect at TCT 2015 Caitlin E. Cox October 05, 2015
News Features Amid Resistance, Support Growing for Safety Checklists in the Cath Lab Caitlin E. Cox April 03, 2015